Positive Phase III Results For Relenza Follow-On Owned By Aussie Biotech Biota And Daiichi Sankyo
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese approval is anticipated in 2010, but Biota is seeking an ex-Japan development partner to replicate Asian studies and seek U.S. and European approvals.